STOCK TITAN

[144] Fortrea Holdings Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A shareholder of FTRE has filed a notice of intent to sell 27,736 shares of common stock under Rule 144. The shares are to be sold through Fidelity Brokerage Services LLC on the NASDAQ, with an indicated aggregate market value of $431,935.49. As context, the filing reports 92,400,000 shares of this class of common stock outstanding.

The securities to be sold were acquired on 01/02/2026 via restricted stock vesting from the issuer as compensation, with the same date listed as the payment date. The section covering securities sold during the past three months does not show additional transactions in this excerpt. By signing, the seller represents they are not aware of undisclosed material adverse information about the issuer’s current or prospective operations.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Fortrea Holdings

NASDAQ:FTRE

FTRE Rankings

FTRE Latest News

FTRE Latest SEC Filings

FTRE Stock Data

1.52B
91.88M
0.5%
111.46%
11.57%
Biotechnology
Services-medical Laboratories
Link
United States
DURHAM